Barclays analyst Matt Miksic raised the firm’s price target on Stryker to $314 from $283 and keeps an Overweight rating on the shares ahead of the Q1 results.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SYK: